Overprescribed and Overused
With so many Prescriptions for gabapentin being written for Medicare recipients, I imagine the government will have to step in at some point.
Select Page
by C. Scott McMillin | Sep 16, 2024 | Addictive Substances | 0 |
With so many Prescriptions for gabapentin being written for Medicare recipients, I imagine the government will have to step in at some point.
by C. Scott McMillin | Apr 11, 2024 | In the News | 0 |
by C. Scott McMillin | Apr 1, 2024 | Public Policy | 0 |
by C. Scott McMillin | Mar 7, 2024 | In the News | 0 |
by C. Scott McMillin | Feb 26, 2024 | In the News | 0 |
by C. Scott McMillin | Feb 5, 2024 | In the News | 0 |
by C. Scott McMillin | Sep 28, 2023 | In the News | 0 |
The DEA has committed to a public information campaign around the theme of “one pill can kill”. Although that’s technically true, I don’t know how much impact it will have on the target audience.
Read Moreby C. Scott McMillin | Sep 21, 2023 | Addictive Substances | 0 |
Yes, they’re effective — for a week or two. After that, most of their effectiveness has eroded. If someone is still taking them on a daily basis, it’s probably an indication of growing dependence
Read Moreby C. Scott McMillin | Sep 7, 2023 | In the News | 0 |
…some patients feel ‘gypped’ if they don’t leave the office with a prescription. And respond with a bad review on the patient satisfaction survey.
Read Moreby C. Scott McMillin | Jul 27, 2023 | Addictive Substances | 0 |
…the research team said their finding “raises serious questions about the use of opioid therapy for acute low back and neck pain.” Such as, why risk it? If it isn’t effective, and for some, can make things worse.
Read Moreby C. Scott McMillin | Jun 26, 2023 | Thinking About Addiction | 0 |
This in spite of the fact … that these drugs can and often do interact harmfully with one another. And regular users are at elevated risk for misuse, abuse, dependence, and/or addiction.
Read Moreby C. Scott McMillin | May 15, 2023 | In the News | 0 |
So in addition to the upsurge in prescribing via telehealth, our current shortage relates to far more frequent use of the medication to treat the adult variant of ADHD.
Read Moreby C. Scott McMillin | Apr 3, 2023 | Addictive Substances | 0 |
Anybody concerned that some GHB-based prescribed meds will be diverted for illicit use?
Read Moreby C. Scott McMillin | Oct 10, 2022 | Addictive Substances | 0 |
I was surprised to learn that the antidepressant effects of ketamine were completely blocked by naltrexone, an opioid antagonist. That certainly suggests ketamine is making use of the brain’s opioid systems…
Read Moreby C. Scott McMillin | Aug 15, 2022 | Thinking About Addiction | 0 |
I did ask a veteran ER physician for one suggestion that he felt would actually help both doctor and patient in the ER setting. His answer: Peer Support services.
Read Moreby C. Scott McMillin | May 9, 2022 | Addictive Substances | 0 |
It’s possible something similar is happening today, perhaps not with an opioid but with some other class of drug. Maybe we simply aren’t aware of it yet.
Read Moreby C. Scott McMillin | Apr 14, 2022 | Addictive Substances | 0 |
A family physician in New Mexico mentioned having seen several new patients, all young, over the course of a few weeks – all of whom claimed to be on unusually high-doses of the drug, and seeking new prescriptions.
Read Moreby C. Scott McMillin | Mar 31, 2022 | Treatment | 0 |
“How many fewer days?” was my question. Looks like about 10%.
So if the subject ordinarily drank every day, they eliminated one drinking day in ten?